Successful Issue of the Entitlement Offer Shortfall
Filed with ASX · · 1 page · English
Story so far
Earlier from Biotron
- Quarterly Activities/Appendix 4C Cash Flow Report
- Security Class Reinstatement to Quotation - BITO
- Rights Issue Close
- Security Class Suspension from Quotation - BITO
- Non-Renounceable rights Issue Prospectus
Later from Biotron
- Half Yearly Report and Accounts
- Hepatitis B Virus Program Update
- $525K R&D Rebate Received
- Sedarex First Milestone Met
- HBV Treatment to Progress Towards Human Trials
Follow Biotron into a list and get an email when it puts out news.
Follow Biotron